Solid Biosciences (SLDB) Interest Coverage Ratio (2023 - 2025)
Solid Biosciences' (SLDB) quarterly Interest Coverage Ratio came in at 9880.6 in Q4 2025, down 1757.44% year-on-year from 596.14 in Q4 2024, and down 7008.07% quarter-over-quarter from 143.03 in Q3 2025.
Solid Biosciences (SLDB) Interest Coverage Ratio (2023 - 2025) Analysis & Trends
Solid Biosciences has disclosed Interest Coverage Ratio across 3 years of filings, most recently posting 9880.6 for Q4 2025.
- Interest Coverage Ratio for Q4 2025 came in at 9880.6, down 1757.44% year-over-year; the trailing twelve-month figure through Mar 2026 was 724.95 (up 258.77% YoY), and the FY2025 annual result was 882.79, up 331.37% from the prior year.
- Interest Coverage Ratio came in at 9880.6 for Q4 2025 at Solid Biosciences, down from 143.03 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 143.03 in Q3 2025 to a low of 9880.6 in Q4 2025.
- The 3-year median for Interest Coverage Ratio is 299.27 (2024), against an average of 1127.17.
- Peak annual rise in Interest Coverage Ratio reached 133.34% in 2025, while the deepest fall reached 1757.44% in 2025.
- Solid Biosciences' Interest Coverage Ratio stood at 220.45 in 2023, then tumbled by 141.31% to 531.95 in 2024, then plunged by 1757.44% to 9880.6 in 2025.
- The last three Interest Coverage Ratio figures came in at 9880.6 (Q4 2025), 143.03 (Q3 2025), and 694.88 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -258.33 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 11.79 |
| 10 | Solid Biosciences | 789.54 Mn | 408.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -9,880.60 |
| Sep 30, 2025 | 143.03 |
| Jun 30, 2025 | -694.88 |
| Mar 31, 2025 | -589.00 |
| Dec 31, 2024 | -531.95 |
| Sep 30, 2024 | -429.05 |
| Jun 30, 2024 | -315.77 |
| Mar 31, 2024 | -282.76 |
| Dec 31, 2023 | -220.45 |
| Sep 30, 2023 | -218.06 |
| Jun 30, 2023 | -241.83 |
| Mar 31, 2023 | -264.71 |